manufacturing

Manufacturing

MANUFACTURING

APIs & Intermediates

APIs & Intermediates

apis

 

CLL has a dedicated facility capable of manufacturing several APIs and Intermediates in bulk quantities. All procedures are followed as per cGMP Guidelines with a well trained team. Working environment and safety standards are maintained and adhered with utmost importance.

Operations are carried out in an organised manner right from procurement of raw materials till dispatch of finished goods thereby maintaining and improving upon complete life cycle assessment of product. Numerous Glass Lined Reactors and Stainless Steel reactors are installed to scale up the capacity into multi tons. Separation and drying procedures are carried out in classified zones with specialised equipments complying with cGMP norms. Critical parameters are controlled under strict quality vigilance resulting in efficient batch process manufacturing throughout every stage.

All the production effluents are treated separately in ETP as per pollution control board guidelines and thus a clean environment is maintained.

Products

Products

manufacturing

APIs with DMF/COS or European Registered Drug Dossiers are suitably indicated in brackets. [Products protected by valid patents are not offered for sale in countries where the sale of such products constitutes a patent infringement. The liability of any sale into such protected markets is at buyer’s risk.

Regular APIs

Products Therapeutic Category
Clopidogrel Bisulphate (Form I and Form II) Anti-Platelets
Rosuvastatin Calcium Anti-Hyperlipidemic
Levetiracetam Anti-Convulsant
Citicoline Sodium Psychotherapeutic
Rifaximin Anti-Diarrhea
Pregabalin Anti-Convulsant

Under development

Products Therapeutic Category
Luliconazole Anti-Fungal
Sertaconazole Anti-Fungal
Ticagrelor Anti-Platelets
Prasugrel Anti-Platelets
Pitavastatin Anti-Hyperlipidemic
Rivaroxaban Anti-Coagulant
Apixaban Anti-Coagulant
Brivaracetam Anti-Convulsant